These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4108397)

  • 21. Vaginal cytology in patients treated with steroid combinations.
    de Chiaffitelli HS; Domínguez S
    Acta Cytol; 1970 May; 14(5):344-7. PubMed ID: 4104951
    [No Abstract]   [Full Text] [Related]  

  • 22. [A serial method for ovulation inhibition using ethinyl estradiol].
    McBride WG
    Arzneimittelforschung; 1969 Aug; 19(8):1271-3. PubMed ID: 5820291
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sequential therapy in menstruation disorders].
    Gaudefroy M; Lefebvre F
    J Sci Med Lille; 1968 Oct; 86(10):581-606. PubMed ID: 4097276
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature].
    Pellegrini R; Seassaro E
    Quad Clin Ostet Ginecol; 1969 Sep; 24(9):597-617. PubMed ID: 4926507
    [No Abstract]   [Full Text] [Related]  

  • 25. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of variation in estrogen dosage on the pregnancy rate during sequential oral contraception.
    Liggins GC
    Fertil Steril; 1967; 18(2):191-7. PubMed ID: 5336044
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological inhibition of ovulation].
    Haller J
    Fortschr Geburtshilfe Gynakol (1950); 1965; 21():37-106. PubMed ID: 12255694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacology of reproduction: oral contraceptives].
    Radouco-Thomas S
    Laval Med; 1968 May; 39(5):383-96. PubMed ID: 4180715
    [No Abstract]   [Full Text] [Related]  

  • 30. Failures of contraception on the lower dose ethinyl estradiol sequential therapy: a clinical trial.
    Miyamoto J
    Am J Obstet Gynecol; 1970 Nov; 108(6):990-1. PubMed ID: 4098757
    [No Abstract]   [Full Text] [Related]  

  • 31. Current research in steroid contraception.
    Tyler ET
    J Reprod Fertil; 1969 Nov; 20(2):319-30. PubMed ID: 4186798
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibitors of ovulation as inhibitors of proliferation].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1973 Jan; 33(1):23-7. PubMed ID: 4119488
    [No Abstract]   [Full Text] [Related]  

  • 33. [Peroral contraception (1): drugs].
    Dolby J; Kronberg L
    Lakartidningen; 1970 Jun; 67():Suppl III:33+. PubMed ID: 4097872
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of family planning. V. Contraceptive methods in women].
    Castelazo-Ayala L; Zárate-Treviño A
    Gac Med Mex; 1968 Sep; 98(9):1138-47. PubMed ID: 5719858
    [No Abstract]   [Full Text] [Related]  

  • 37. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)].
    Gueguen J
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early tubal abortion during oral contraception].
    Köpernik H; Timmel H
    Zentralbl Gynakol; 1972 Sep; 94(38):1248-52. PubMed ID: 4118175
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peroral contraception (5): continuing low dosage treatment].
    Larsson-Cohn U
    Lakartidningen; 1970 Jun; 67():Suppl III:56+. PubMed ID: 4097873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.